Last updated: January 25, 2021
Sponsor: Chinese University of Hong Kong
Overall Status: Completed
Phase
2/3
Condition
Anxiety Disorders
Panic Disorders
Schizotypal Personality Disorder (Spd)
Treatment
N/AClinical Study ID
NCT04091139
UPAHK01
Ages 13-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age between 13 to 18 years.
- Primary diagnosis of any depression and/or anxiety disorders in fifth edition of theDiagnostic and Statistical Manual
- Use Chinese as primary written language
- For adolescents on medication, there must be 6-week stabilization period before studyentry
Exclusion
Exclusion Criteria:
- Diagnoses of psychotic disorders, organic brain disease, bipolar disorder
- In high risk of self-harm or suicide
- Significant cognitive impairment (intellectual quotient lower than 80)
- Autism Spectrum Disorders
- Externalizing disorders with serious treatment interfering disruptive behaviouralproblems or substance abuse
- Attending concurrent psychotherapy
- Experience of attending a full-course of cognitive behavior therapy for anxiety ordepression
Study Design
Total Participants: 27
Study Start date:
September 24, 2019
Estimated Completion Date:
May 22, 2020
Study Description
Connect with a study center
Department of Psychology, The Chinese University of Hong Kong
Hong Kong, HK HK
Hong KongSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.